Creating a Platform to Cure the Most Difficult Diseases
MiCAN will accelerate infectious disease research through special cells created with regenerative medicine technology. Many bio ventures are focusing on transplantation material or tissue using regenerative medicine technologies. But we focus on immature or intermediate blood cells that are difficult to collect from donor blood. Initially we are developing our products for infectious disease. One of our core technologies is the differentiation methods how to provide these young cells. Most of our customers are in abroad because of the target disease. So, we will provide our product from Japan to all over the world.
Background: Drug researcher at Pharma Co.
Expertise: Small molecule drugs / Regenerative Medicine
Background: Product development at Pharma Co.
Expertise: Cell engineering / Regenerative Medicine